Good MorningThe FOMC held its June policy meeting this week and gave the market exactly what it wanted. The Fed says it will continue to support the economy via bond purchases and zero or near-zero interest rates through 2022.
The caveat is that near-term prospects are still dire. The economy is expected to contract sharply in the first half but just how sharply is yet to be seen. The Atlanta Fed’s GDPNow tool is tracking near the -50% mark for the 2nd quarter and the FOMC sees full-year 2020 coming in near -6.5%.
What investors need to focus on is the FOMC's outlook for rebound. Although there is going to be a sharp, severe contraction in GDP in the 2 nd quarter the rebound is already underway. The U.S. economy should see sequential quarterly growth resume as soon as the 3 rd quarter and accelerate over the next two to three. Featured: America's #1 Stock Picker Reveals Next 1,000% Winner (free) (IPM) 
|
Markets | | |
Sometimes you can distill the performance of an entire market based on a handful of stocks, or even just one. It's often connected to a range of other operations, and thus, if it performs poorly, many others are too. It's why copper is often called “Dr. Copper,” thanks to its connectio... Read the Full Story |
|
From Our PartnersMarketBeat All Access is our premier research platform that includes MarketBeat Daily Premium, portfolio monitoring tools (My MarketBeat), MarketBeat's full suite of research tools and stock screeners, a real-time news feed, email and SMS alerts, the MarketBeat Idea Engine, proprietary brokerage rankings, extended data export tools and much more. You will also get access to our full database of more than 1 million analyst recommendations, our proprietary broker performance and accuracy ratings and other exclusive benefits.
Through tomorrow night, if you click the link below you will get MarketBeat's flagship subscription, All Access for just $1.00 for your first 30-days. If you want to continue your subscription after that, you'll get a 50% discount on your first year ($19.97 per month instead of $39.97 per month).
| | Start Your 30-Day Risk-Free Trial Subscription Here |
|
Markets | | | Don’t Chase Prices, Let Prices Come To You
If you missed out on the rebound or have chosen not to chase prices the market is giving you what you wanted; a pullback. The futures are indicating a decline of -1.75% to -3.5% across the major indices (SPY) and offering the first really attra... Read the Full Story |
|
Markets | | | Restaurant gaming operator Dave and Busters (NASDAQ: PLAY) shares have quadrupled since its pandemic lows of $4.61 in March 2020. With all 137 locations shut down from the stay-in-shelter mandates since Mar. 20th, revenues have been frozen heading into the Q1 2020 earnings release. Due out Jun. 11, ... Read the Full Story |
|
|
Stocks | | | For a while at least on Wednesday, the fabled FAANG group of tech stocks was sliced and diced and all talk was about the leaner, cleaner FAAM group. They were just the shiniest of the bunch in a week that saw investors continuing to flood back into equities as hopes of a fast recovery continued.
Th... Read the Full Story |
|
Markets | | | Holding Tesla shares in 2020 has not been for the faint of heart. The electric-car maker’s stock burst out of the gates at the start of the year and had doubled by the end of January to fresh all-time highs of $969/share. Shares then fell more than 60% through the middle of March as investors ... Read the Full Story |
|
|
The Early Bird Stock Of The Day Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas. | | View Today's Stock Pick |
|
